NBP Earnings & Financial Statements
NovaBridge Biosciences
$1.40
+$0.02(+1.82%)
34
Overall
60
Value
18
Tech
26
Quality
Market Cap
$160.96M
Volume
295.55K
52W Range
$1.31 - $6.79
Target Price
$8.67
NBP earnings and financial statements: NovaBridge Biosciences's income statement, balance sheet and cash flow statement, annual and quarterly.
NBP Annual Financial Statements
| Fiscal year | 2025 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating income | -$94.27M | - | - | - | - |
| EBITDA | -$87.55M | - | - | - | - |
| Net income | -$46.27M | - | - | - | - |
| EPS (diluted) | $-0.48 | $-13.21 | $-13.35 | $3.00 | $-201.19 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NBP | $1.40 | +1.8% | 295.55K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |